Picture of MindMaze Therapeutics Holding SA logo

MMTX MindMaze Therapeutics Holding SA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Swiss stocks - Factors to watch on August 31

ZURICH/BERLIN, Aug 31 (Reuters) - Here are some of the
main factors that may affect Swiss stocks on Thursday:
    
    UBS GROUP AG  UBSG.S 
    Second quarter results due.
    Insurers were expected to face claims for billions of
dollars from Hurricane Idalia which made landfall in Florida on
Wednesday. In Florida, UBS bank estimated average insured losses
of $9.36 billion with a 50% chance of losses of over $4.05
billion and a 10% likelihood of losses of $25.6 billion, based
on Aug. 28 data. 
    
    EMS CHEMIE  EMSN.S 
    Reported first half net income of 247 million Swiss francs.
    
    ANALYSTS' VIEWS
    FLUGHAFEN ZUERICH AG  FHZN.S : CREDIT SUISSE RAISES TARGET
PRICE TO CHF 220 FROM CHF 203
    
    COMPANY STATEMENTS
    *Relief Therapeutics  RLFB.S  announces new exclusive
definitive license agreement for Olpruva with Acer Therapeutics
 ACER.O   RLFB.S 
    *Brazil's Guararapes says it has renewed its partnership
with Zurich Insurance Group  ZURN.S  to offer its products in
more than 330 Riachuelo stores, according to a filing.  ZURN.S 
    
    ECONOMY
    Swiss July retail sales due at 0630 GMT.
    

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on MindMaze Therapeutics Holding SA

See all news